Tradename: ABRYSVO Proper Name: Respiratory Syncytial Virus Vaccine Indication: Indicated for active immunization of pregnant individuals at 32 through 36 weeks gestational age for the prevention of lower respiratory…
Researchers have found a potential new and less risky treatment for thrombosis. Various medical circumstances, including heart attacks and extreme cases of COVID-19, necessitate the use of anticoagulants, medicines that…
Drug Name: Veopoz Indications: To treat patients 1 year old and older with CD55-deficient protein-losing enteropathy (PLE), also known as CHAPLE disease. Active Ingredient: Pozelimab-bbfg Company: Regeneron Pharmaceuticals, Inc. Approval…
Olive’s AI platform automates some the mundane and repetitive facility tasks, and helps free up more time for clinicians and admin to focus on other more important tasks. Description The…
A cloud-based service that calls up quick, credible information for both staff and patients. Description Microsoft Azure sources from top authorities like the US Food and Drug Administration (FDA) and…
Drug Name: Sohonos Indications: To reduce the volume of new heterotopic ossification in adults and pediatric patients (aged 8 years and older for females and 10 years and older for…
iz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced it has received a De Novo approval by the U.S. Food and Drug Administration (FDA) for its…
Drug Name: Elrexfio Indications: To treat adults with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy. Active Ingredient: Elranatamab-bcmm Company: Pfizer Inc Approval…
Drug Name: Talvey Indications: To treat adults with relapsed or refractory multiple myeloma who have received at least four prior therapies. Active Ingredient: Talquetamab-tgvs Company: Janssen Pharmaceutical Companies Approval Date:…
Drug Name: Zurzuvae Indications: To treat postpartum depression. Active Ingredient: Zuranolone Company: Biogen Inc Approval Date: 8/4/2023 More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217369s000lbl.pdf